These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 22812611)
1. Do ICD lead recalls affect physician--or patient--behavior? If not, why not? Lewis R; Daubert JP J Cardiovasc Electrophysiol; 2012 Aug; 23(8):866-8. PubMed ID: 22812611 [No Abstract] [Full Text] [Related]
2. Impact of a recent lead recall on utilization of implantable cardioverter defibrillators: data from the NCDR ICD Registry™. Bhatt P; Curtis J; Wang Y; Lampert R J Cardiovasc Electrophysiol; 2012 Aug; 23(8):861-5. PubMed ID: 22452744 [TBL] [Abstract][Full Text] [Related]
3. Awareness of indications for device therapy among a broad range of physicians: a survey study. Hübinette C; Lund LH; Gadler F; Ståhlberg M Europace; 2014 Nov; 16(11):1580-6. PubMed ID: 24451291 [TBL] [Abstract][Full Text] [Related]
4. Kidney function and appropriateness of device therapies in adults with implantable cardioverter defibrillators. Bansal N; Szpiro A; Masoudi F; Greenlee RT; Smith DH; Magid DJ; Gurwitz JH; Reynolds K; Tabada GH; Sung SH; Dighe A; Cassidy-Bushrow A; Garcia-Montilla R; Hammill S; Hayes J; Kadish A; Sharma P; Varosy P; Vidaillet H; Go AS Heart; 2017 Apr; 103(7):529-537. PubMed ID: 27742796 [TBL] [Abstract][Full Text] [Related]
5. Temporal Trends Over a Decade of Defibrillator Therapy for Primary Prevention in Community Practice. Boveda S; Narayanan K; Jacob S; Providencia R; Algalarrondo V; Bouzeman A; Beganton F; Defaye P; Perier MC; Sadoul N; Piot O; Klug D; Gras D; Fauchier L; Bordachar P; Babuty D; Deharo JC; Leclercq C; Marijon E; J Cardiovasc Electrophysiol; 2017 Jun; 28(6):666-673. PubMed ID: 28251724 [TBL] [Abstract][Full Text] [Related]
14. Implantable Defibrillator Timing Windows: When Coincidence Can Be Confusing. Jackson N; Viswanathan K; Cameron D; Nair K Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e002876. PubMed ID: 26902146 [No Abstract] [Full Text] [Related]
15. Deactivation of implantable cardioverter-defibrillators: results of patient surveys. Herman D; Stros P; Curila K; Kebza V; Osmancik P Europace; 2013 Jul; 15(7):963-9. PubMed ID: 23447573 [TBL] [Abstract][Full Text] [Related]
16. The implantable cardioverter-defibrillator: An update. Miller JD; Yousuf O; Berger RD Trends Cardiovasc Med; 2015 Oct; 25(7):606-11. PubMed ID: 25912255 [TBL] [Abstract][Full Text] [Related]
17. Clinical Outcomes of Single- versus Dual-Chamber Implantable Cardioverter Defibrillators: Lessons from the Israeli ICD Registry. Konstantino Y; Haim M; Boxer J; Goldenberg I; Feldman A; Michowitz Y; Glikson M; Suleiman M; J Cardiovasc Electrophysiol; 2016 Jun; 27(6):718-23. PubMed ID: 26852908 [TBL] [Abstract][Full Text] [Related]
18. Heartbeat: Prevention of sudden cardiac death. Otto CM Heart; 2016 May; 102(10):729-30. PubMed ID: 27114504 [No Abstract] [Full Text] [Related]
19. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon. Boriani G; Braunschweig F; Deharo JC; Leyva F; Lubinski A; Lazzaro C Europace; 2013 Oct; 15(10):1453-62. PubMed ID: 23696624 [TBL] [Abstract][Full Text] [Related]
20. Time dependence of risks and benefits in pediatric primary prevention implantable cardioverter-defibrillator therapy. DeWitt ES; Triedman JK; Cecchin F; Mah DY; Abrams DJ; Walsh EP; Gauvreau K; Alexander ME Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1057-63. PubMed ID: 25262116 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]